MedTrace Logo

Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis

NCT01049152 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 36

Last updated 2022-05-24

No results posted yet for this study

Summary

Evaluation of different glycemic variations between the dialysis period and non-dialysis period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The investigators will evaluate also inflammation markers before and after the different hemodialysis methods.

Conditions

Interventions

DEVICE

Continuous Glucose Monitoring (CGM)

CGM allocated one time for 3 days

Sponsors & Collaborators

  • University of Pavia

    lead OTHER

Principal Investigators

  • Giuseppe Derosa, MD, PhD · University of Pavia- Fondazione IRCCS Policlinico San Matteo

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2014-05-19
Completion
2014-12-22

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01049152 on ClinicalTrials.gov